scholarly article | Q13442814 |
P819 | ADS bibcode | 1987PNAS...84.2287K |
P356 | DOI | 10.1073/PNAS.84.8.2287 |
P932 | PMC publication ID | 304635 |
P698 | PubMed publication ID | 3470793 |
P5875 | ResearchGate publication ID | 19685133 |
P2093 | author name string | Kovanen PT | |
Kokkonen JO | |||
P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition | Q28625661 | ||
Insoluble low-density lipoprotein-proteoglycan complexes enhance cholesteryl ester accumulation in macrophages | Q35835281 | ||
Electron microscope observations on compounds 48-80-induced degranulation in rat mast cells. Evidence for sequential exocytosis of storage granules | Q36503120 | ||
Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins | Q40099596 | ||
The mast cell | Q40103692 | ||
Basophils and mast cells: morphologic insights into their biology, secretory patterns, and function | Q40116600 | ||
Structure and function of the chemical mediators of mast cells | Q40140643 | ||
Degradation of low density lipoprotein . dextran sulfate complexes associated with deposition of cholesteryl esters in mouse macrophages | Q40238746 | ||
Inhibition of phagocytosis and plasma membrane mobility of the cultivated macrophage by cytochalasin B. Role of subplasmalemmal microfilaments | Q41182472 | ||
Uptake and degradation of mast-cell granules by mouse peritoneal macrophages | Q41902395 | ||
Complexes of low-density lipoproteins and arterial proteoglycan aggregates promote cholesteryl ester accumulation in mouse macrophages | Q41916327 | ||
The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. | Q41926217 | ||
Low-density-lipoprotein binding by mast-cell granules. Demonstration of binding of apolipoprotein B to heparin proteoglycan of exocytosed granules | Q42855316 | ||
Regulation of cholesterol synthesis and storage in fat cells | Q51673608 | ||
Mast cells in human aorta | Q66994688 | ||
Low density lipoprotein degradation by rat mast cells. Demonstration of extracellular proteolysis caused by mast cell granules | Q69913624 | ||
Degradation of the heparin matrix of mast cell granules by cultured fibroblasts | Q71831691 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lipoprotein | Q28350 |
mast cell | Q191989 | ||
P1104 | number of pages | 5 | |
P304 | page(s) | 2287-2291 | |
P577 | publication date | 1987-04-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Stimulation of mast cells leads to cholesterol accumulation in macrophages in vitro by a mast cell granule-mediated uptake of low density lipoprotein | |
P478 | volume | 84 |
Q64276506 | Acute and Chronic Effects of Cocaine on Cardiovascular Health |
Q37739235 | Biochemistry of the arterial wall in developing atherosclerosis |
Q26825467 | Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases |
Q35014223 | Enhanced vascular permeability facilitates entry of plasma HDL and promotes macrophage-reverse cholesterol transport from skin in mice. |
Q78257763 | Immunological modulation of human cardiac mast cells |
Q36705726 | Macrophages and Oxidized Low Density Lipoproteins in the Pathogenesis of Atherosclerosis |
Q40159308 | Management of atherosclerosis with antiallergic medicine: a lesson from the mouse model |
Q28388340 | Manufactured and airborne nanoparticle cardiopulmonary interactions: a review of mechanisms and the possible contribution of mast cells |
Q58153662 | Mast Cell Granule-Mediated Uptake of Low Density Lipoproteins by Macrophages: A Novel Carrier Mechanism Leading to the Formation of Foam Cells |
Q90079376 | Mast Cells as Potential Accelerators of Human Atherosclerosis-From Early to Late Lesions |
Q91802489 | Mast Cells in Cardiovascular Disease: From Bench to Bedside |
Q37578873 | Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases |
Q37312777 | Mast cells and acute coronary syndromes: relationship between serum tryptase, clinical outcome and severity of coronary artery disease |
Q35106076 | Mast cells and metabolic syndrome |
Q99419174 | Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts |
Q26995160 | Mast cells as effectors in atherosclerosis |
Q38563903 | Mast cells in human and experimental cardiometabolic diseases |
Q38007884 | Mast cells: an expanding pathophysiological role from allergy to other disorders |
Q42796812 | Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages |
Q41162467 | Oxidative modification of low-density lipoprotein by the human hepatoma cell line HepG2. |
Q33850346 | Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation |
Q41048276 | Proteoglycans in macrophages: characterization and possible role in the cellular uptake of lipoproteins |
Q35557630 | Regulation of smooth muscle cell growth, function and death in vitro by activated mast cells--a potential mechanism for the weakening and rupture of atherosclerotic plaques |
Q51835824 | The Innate Immune Response in Myocardial Infarction, Repair, and Regeneration. |
Q39270949 | Transcriptional Profiling Confirms the Therapeutic Effects of Mast Cell Stabilization in a Dengue Disease Model |
Search more.